Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by studpuppyon Jul 15, 2011 12:15pm

200 Views

Post# 18835771

RE: RE: RE: RE: RE: Earnings upgrade

its useless guys level 2 on TH, if you go buy now 20k shares @ market the sp won`t even budge probably go up 2-5 cents when in fact with 20k shares at market should bring you easily to the $4.75 if not higher, we are being controlled ( sp ) extremely well, i`ve done it so many times never worked!!
regards stud

Bullboard Posts

Morning Market Outlook for June 3, 2024